Vous avez cherché: hyperglycemia (Français - Anglais)

role of lxrbeta in glucocorticoid-induced hyperglycemia
the chaplins of streptomyces coelicolor: amyloid formation and cell surface modulation

mir s, taylor d. atypical antipsychotics and hyperglycemia.
14.mir s, taylor d. atypical antipsychotics and hyperglycemia.

this could be hyperglycemia, infections, or neoplastic lesions.
this could be hyperglycemia, infections, or neoplastic lesions.

nonketotic hyperglycemia patients with nonketotic hyperglycemia can develop hemiballismus as a complication to the disease through the development of a subthalamic nucleus lesion.
nonketotic hyperglycemiapatients with nonketotic hyperglycemia can develop hemiballismus as a complication to the disease through the development of a subthalamic nucleus lesion.

while the hyperglycemia itself is not the cause of the hemiballistic movements, it has been suggested that petechial hemorrhage or a decreased production of gaba and acetylcholine could result secondary to the hyperglycemia.
while the hyperglycemia itself is not the cause of the hemiballistic movements, it has been suggested that petechial hemorrhage or a decreased production of gaba and acetylcholine could result secondary to the hyperglycemia.

overexpression of glyoxalase-i in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia- induced increases in macromolecular endocytosis.
overexpression of glyoxalase-i in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis.

l'étude insight (implementing new strategies with insulin glargine for hyperglycemia therapy/implantation de nouvelles stratégies pour le traitement de l'hyperglycémie avec l'insuline glargine), présentée lors de la 65e rencontre annuelle de l'american diabetes association par le dr hertzel gerstein, chercheur principal de l'étude, professeur de médecine et directeur de la division endocrinologie et métabolisme de l'université mcmaster de hamilton, a démontré que l'introduction de l'insuline glargine très tôt dans le schéma thérapeutique (seule ou associée à des agents hypoglycémiants oraux) pouvait permettre d'atteindre en toute sécurité de meilleurs résultats sur les plans glycémique et métabolique que le renforcement du traitement avec des agents oraux seulement.
the insight study (implementing new strategies with insulin glargine for hyperglycemia therapy), presented at the 65th american diabetes association annual meeting and scientific sessions by lead investigator, dr. hertzel gerstein, a professor of medicine and director of endocrinology and metabolism at mcmaster university in hamilton, demonstrated that early addition of insulin glargine therapy (in combination with oral agents or alone) safely achieved better glycemic and metabolic outcomes than adding oral agents.